| Pharmaceutical active ingredients: |
| Alfuzosin Hydrochloride |
| Available forms, composition and doses of Ranplasia-OD: |
| Tablets, Extended Release; Oral; Alfuzosin Hydrochloride 10 mg |
| Ranplasia-OD medical category: |
| Human:Drugs for bladder and prostate disordersSelective alfa-1-adrenergic blocking agents |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| G04CA01 - Alfuzosin |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| Rowfarma de Mexico |
| Trade name |
Active ingredients |
Pharmaceutical company |
|
Trofina | Amino Acids; Multivitamins | Rowe-Fleming Laboratorios |
| Veglysin | Tribenoside | Rowe-Fleming Laboratorios |
| Yerba Santa | Ammonium Citrate; Carbetapentane Citrate; Eriodictyon; Peru Balsam; Polygala; Sodium Benzoate | Rowe-Fleming Laboratorios |
| Pamorelin | Triptorelin Pamoate | Rowfarma de Mexico; Globopharm |
| Pamorelin LA | Triptorelin Pamoate | Rowfarma de Mexico; Globopharm |
| Acarbose | Acarbose | Roxane Laboratories |
| Acetaminophen | Acetaminophen | Roxane Laboratories |
| Acetaminophen; Codeine | Acetaminophen; Codeine Phosphate | Roxane Laboratories |
| Acetaminophen; Codeine N2 | Acetaminophen; Codeine Phosphate | Roxane Laboratories |
| Acetaminophen; Codeine N3 | Acetaminophen; Codeine Phosphate | Roxane Laboratories |